Articles

The number of Americans diagnosed with diabetes — the seventh leading cause of death in the U.S. — has risen by epidemic proportions. In addition, the disease is estimated to affect 435 million people worldwide by 2030. BIO and the Juvenile Diabetes Research Foundation will feature a two-day diabetes forum for the first time at the 2011 BIO International Convention in Washington, DC. The sessions will showcase the latest research in novel therapies, vaccines, and biomarkers.

Scientific American will release the third annual Worldview: A Global Biotechnology Perspective at this year's BIO International Convention.

This week is National Small Business Week (May 16-20). Every year, the president proclaims National Small Business Week to recognize the contributions of small businesses to the economic well-being of America. More than half of all Americans either own or work for a small business. In honor of National Small Business Week, BIO compiled our top 5 strategies for small business success.

The successful construction of a synthesized genome could enable new research and development of human therapies, biofuels, and biobased chemicals from renewable resources.

Emerging biotech companies with promising scientific innovation need a policy environment that will enable them to continue critical research and development of medical advancements and breakthroughs.

This week is National Small Business Week (May 16-20). Every year, the president of the United States proclaims National Small Business Week to recognize the contributions of small businesses to the economic well-being of America.

Providing legal counsel within the biotech industry comes with a unique set of challenges.  Legal professionals must consistently stay on top of the latest policy and regulatory changes within the industry. From patent issues to new laws on licensing to regulations for new innovations, the BIO International Convention (June 27-30) will feature the latest updates, insights and networking opportunities—plus educational sessions where you can earn up to eight CLE credit hours—to help fast-track your career. Sit in on any number of BIO Program presentations by leading law firms and earn CLE credits.

You might have heard that the Prince of Wales, just days after hosting the Royal Wedding, paid us a visit here in Washington.  Prince Charles, a long-time organic food advocate and self-described environmentalist, was here to speak at a Washington Post symposium on the Future of Food.

Prince Charles likes to talk about “sustainability” so much that he used a version of the word 32 times in his recent speech about farming at Georgetown University.

Recently introduced legislation could help the military become the technology leader in scaling up commercial production of sustainable biofuels, such as algae.

Multiple sclerosis (MS) is a complex disease involving immune-system attacks on the central nervous system. Research into MS involves questions that dovetail many fields of science, including immunology, neuroscience, psychology and more.

The world’s largest biotech hubs are busy planning their delegations’ visits to the  BIO International Convention  next month. The international program at the Convention will be one of the most robust to date, with International Case Studies, breakout sessions focused on globalization and Super Sessions focused on the emerging markets.

The keys to successful industrial biotech business relationships mirror those for successful personal relationships, industry leaders explained today.  During the final Lunch Plenary Session of BIO’s 2011 World Congress in Toronto, moderator James Stoppert, CEO of BioAdvisors, along with panelists Patrick Gruber, CEO of Gevo, Ron Commander, Head of Butyl Rubber Business Unit at Lanxess, Christophe Schilling, CEO of Genomatica, and Hisao Urata, General Manager of Corporate Planning at Mitsubishi Chemical discussed “Strategic Partnerships for More Robust Value Chains” and identified some key components to that end.

Today, major players in the clean energy investment community provided key perspective and insight to help inform industrial biotech companies and their future success.

During today’s plenary lunch session at BIO's 2011 World Congress in Toronto, Royal DSM CEO Feike Sijbesma gave a passionate keynote address and accepted the 2011 George Washington Carver Award for his company’s efforts to promote bio-based products over those relying on fossil-fuel resources.

BIOtechNOW’s Tracy Cooley talks to Dr. Jones about the significance and importance of the re; Biotech Humanitarian Award , which will be bestowed on this year’s award winner at the  BIO International Convention during a keynote session on Wednesday, June 29.

Bonnie Fendrock, co-founder, president, and CEO of Hepregen Corporation, talks about her career in the life-sciences industry and the work of Hepregen — including the commercialization of their microliver platform.

With global food costs reaching such dangerous levels, ensuring a safe, affordable and abundant global food supply has never been as important as it is right now.

Thanks to genetic engineering, flowers are heartier and last longer after they’re cut.  And they come in a wider variety of shapes, sizes, scents and colors – even blue!

BIO will be co-hosting an event with the United States Patent and Trademark Office (USPTO) to celebrate the 30th anniversary of the issuance of U.S. patent 4,259,444 to Ananda Chakrabarty following the Supreme Court case, Diamond v. Chakrabarty, which held that Chakrabarty’s bioengineered bacterium was eligible for patenting.

A new report analyzing FDA-approved monoclonal antibodies (mAbs) produced by a select group of leading biotechnology companies shows that clinical development times – specifically the duration of Phase II and Phase III trials – are lengthening, while FDA review times have remained constant.

BIO has named Feike Sijbesma as the recipient of its 2011 George Washington Carver Award for innovation in industrial biotechnology.

Mark Herzog, executive director of the Virginia Biotechnology Association recently discussed the success and challenges facing the burgeoning bioscience industry in his state.

"The Value Proposition for Cellulosic and Advanced Biofuels Under the Federal Renewable Fuel Standard" is forthcoming in the April 2011 Industrial Biotechnology Journal.